Findings

What do systematic reviews say?

5 questions · 5 findings · 5 reviews · Airways

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 60%Moderate 1 · 20%High 1 · 20%

Intravenous magnesium sulfate + standard care vs placebo + standard care

Proportion of people with hospital admissions (from the emergency room) · acute exacerbations of chronic obstructive pulmonary disease

Intravenous magnesium sulfate + standard care may leads to lower proportion of people with hospital admissions (from the emergency… compared with placebo + standard care (low certainty).

1 finding from 1 review

Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease 2022 · Cochrane Headline outcomes only
OR 0.45 [0.23, 0.88]
3 studies · 170 participants
Low

MgSO4 vs placebo

Hospital admissions · children with acute asthma in the emergency department

MgSO4 may leads to lower hospital admissions compared with placebo (low certainty).

1 finding from 1 review

Intravenous magnesium sulfate for treating children with acute asthma in the emergency department 2016 · Cochrane Headline outcomes only
OR 0.32 [0.14, 0.74]
3 studies · 115 participants
Low

Intervention not reported

Hospital admissions · adults with acute asthma

The intervention leads to lower hospital admissions (high certainty).

1 finding from 1 review

Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department 2014 · Cochrane Headline outcomes only
OR 0.75 [0.6, 0.92]
11 studies · 1769 participants
High

Aminophylline vs placebo

Hospital admissions · patients with adults with acute asthma

Aminophylline showed no clear difference in hospital admissions compared with placebo (moderate certainty).

1 finding from 1 review

Addition of intravenous aminophylline to inhaled beta₂‐agonists in adults with acute asthma 2012 · Cochrane Headline outcomes only
OR 0.58 [0.3, 1.12]
6 studies · 315 participants
Moderate

IV + inhaled beta agonist vs inhaled beta‐agonist

Hospital admissions · patients with acute asthma

IV + inhaled beta agonist showed no clear difference in admissions to hospital compared with inhaled beta‐agonist (low certainty).

1 finding from 1 review

Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma 2012 · Cochrane Headline outcomes only
OR 0.29 [0.06, 1.38]
1 study · 29 participants
Low